The Medicines Patent Pool signs a record seven new sub-licences to speed the availability ofgeneric HIV meds to developing countries

The Medicines Patent Pool (MPP) has announced seven new sub-licensing agreements for the manufacture of generic HIV medicines, atazanavir (ATV) and dolutegravir (DTG). The United Nations-backed MPP negotiates licences with key patent holders to speed access of low-cost, generic medicines to developing countries. To date, the MPP has signed agreements with Bristol Myers-Squibb, Gilead Sciences… 

Read the source article at MarketWatch

About the Author

Leave a Reply